Related Experiment Video
Updated: Jan 13, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
A description of antipsychotic prescribing patterns on the inpatient behavioral health setting: a multicenter
Thomas Maestri1, David Anderson2, Margarita Echeverri2
1Xavier University of Louisiana, 1 Drexel Dr, New Orleans, LA 70125-1056, USA.
Background:
Antipsychotic therapy can bring a great deal of benefit to individuals with schizophrenia and other psychiatric diagnoses, though this class of medications is also associated with intolerabilities due to possible adverse events. Notable adverse events commonly experienced include movement disorders and metabolic concerns that can occur even at low doses and minimal exposure.
Objectives:
Describe the prescribing patterns of antipsychotics in the inpatient behavioral health setting, and report on characteristics that lead to populations having higher or lower dosing exposures to antipsychotic therapy that follows FDA guidelines.
Design:
Multicentered, retrospective, cross-sectional chart review.
Methods:
The study was conducted at two academic hospitals in the inpatient behavioral health setting. Information was collected on 785 cases of patients who were hospitalized during the study period with a psychiatric diagnosis that necessitated a prescription for an antipsychotic medication at the time of discharge. Differences in antipsychotic drug (dose, type, number, and duration of treatment) were characterized, and data were collected on clinician adherence to FDA guidance, as listed in the package insert of each antipsychotic drug. Primary outcomes were the amount of Total Chlorpromazine Equivalent Dosing doses and the clinician's adherence to FDA guidance.
Results:
This study found that the male gender (p < 0.0001), no social support (p < 0.0025), more previous antipsychotic trials (p < 0.0001), and longer hospital stays (p < 0.0001) were statistically significant for patients receiving higher antipsychotic doses at discharge. Additionally, patients with comorbid diabetes (p < 0.0001), more antipsychotics at discharge (p = 0.001), and Medicare insurance (p = 0.005) were less likely to receive antipsychotic medication following FDA recommendations and current guidelines.
Conclusion:
The results of this study can inform practice regarding antipsychotic prescribing patterns in different populations. Conducting prospective studies across a broader range of institutions, it is recommended to better understand the relationship between patient demographics and prescribing patterns during periods of acute illness.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Pharmacodynamics in Geriatric Patients: Effects of Age